Which syndrome is associated with simultaneous marked elevations of lactate and ferritin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Hemophagocytic Lymphohistiocytosis (HLH)

The syndrome causing simultaneous marked elevations of lactate (lactate dehydrogenase/LDH) and ferritin is Hemophagocytic Lymphohistiocytosis (HLH), a hyperinflammatory disorder characterized by excessive activation of cytotoxic T cells, NK cells, and macrophages. 1

Clinical Hallmarks

HLH presents with a characteristic constellation of findings 1:

Core clinical features:

  • Persistent fever
  • Hepatosplenomegaly
  • Cytopenias (affecting multiple cell lines)

Characteristic laboratory abnormalities:

  • Markedly elevated ferritin (often >500 ng/mL, frequently >10,000 ng/mL)
  • Elevated lactate dehydrogenase (LDH)
  • Elevated triglycerides
  • Elevated soluble CD25
  • Elevated transaminases
  • Elevated D-dimers
  • Decreased fibrinogen
  • Decreased albumin
  • Decreased sodium

Diagnostic Approach

When to Suspect HLH

The diagnosis requires clinical judgment about whether the combination, extent, and progression of abnormalities are unusual, unexpected, and otherwise unexplained 1. This is critical because many individual findings can occur in other conditions.

Key diagnostic principle: Despite the name, hemophagocytosis in bone marrow is neither sensitive nor specific—it was present in only 53% of confirmed cases in one series 2 and may occur in other conditions like septicemia 1.

HLH-2004 Diagnostic Criteria

While these criteria have substantial weaknesses in malignancy-associated cases, they serve as a working framework 1:

  • Fever
  • Splenomegaly
  • Cytopenias (affecting ≥2 cell lines)
  • Hypertriglyceridemia and/or hypofibrinogenemia
  • Hemophagocytosis in bone marrow, spleen, or lymph nodes
  • Low or absent NK cell activity
  • Ferritin ≥500 ng/mL
  • Elevated soluble CD25

Clinical Context Matters

Age-Related Considerations

The likelihood of underlying malignancy increases dramatically with age 1:

  • Adults >60 years: 68% have underlying lymphoma
  • Adults 30-59 years: 38% have lymphoma
  • Ages 15-29 years: 10% have lymphoma
  • Children <14 years: 0% have lymphoma

In adults overall, nearly half of HLH cases are triggered by malignancy, with approximately 1% of patients with hematologic malignancies developing HLH 1.

Primary vs. Secondary HLH

Primary (hereditary) HLH can occur in adults and adolescents, not just children 1. X-linked lymphoproliferative syndrome (XLP) has the strongest association with malignancy-triggered HLH 1.

Secondary HLH triggers include:

  • Infections (especially EBV, CMV)
  • Malignancies (particularly lymphomas)
  • Autoimmune/autoinflammatory conditions (including systemic lupus erythematosus) 2

Critical Pitfalls

Delayed Diagnosis is Fatal

One case report documented a 30-year-old woman whose diagnosis was delayed by one month beyond presentation—she initially improved with treatment but died 5 months later from progressive HLH 3. Early recognition and treatment are essential to prevent irreversible multi-organ failure and death.

Malignancy Masquerading as HLH

In elderly patients with apparent autoimmune disease, occult T-cell lymphoma can mimic or coexist with conditions like dermatomyositis while presenting with the HLH laboratory pattern (elevated LDH, ferritin, and soluble IL-2 receptor) 4. Repeat tissue evaluation, particularly of skin lesions, may be critical in atypical or treatment-refractory cases.

Context-Specific Interpretation

In patients on tocilizumab (IL-6 inhibitor), ferritin and CRP may remain falsely normal during relapse, making LDH and white blood cell count more reliable markers 5.

Workup for Underlying Malignancy

All patients with HLH require evaluation for occult malignancy 1:

Minimum evaluation:

  • Peripheral blood and bone marrow screening for blasts
  • Chest X-ray
  • Abdominal ultrasound or CT
  • Biopsy of suspicious lymph nodes or skin lesions

In high-risk patients (older age, atypical features):

  • CT or MRI imaging
  • Consider PET scan
  • Brain MRI if neurological symptoms present
  • CSF analysis for CNS involvement

Related Conditions

Macrophage Activation Syndrome (MAS) is a form of secondary HLH occurring in rheumatologic conditions. In childhood-onset SLE, optimal cutoff values predicting MAS were: ferritin ≥607 ng/mL, LDH ≥424 U/L, and AST ≥61 U/L 2.

References

Related Questions

In a 66-year-old woman with markedly elevated ferritin, high transferrin saturation, mildly elevated alkaline phosphatase, hyperlipidemia (total cholesterol 222 mg/dL, low‑density lipoprotein 129 mg/dL, triglycerides 182 mg/dL, high‑density lipoprotein 62 mg/dL) while taking atorvastatin, and mild eosinophilia, what management steps should be taken for these abnormal laboratory values?
In a 68-year-old man with moderately elevated AST (~140 U/L) and ALT (~145 U/L), normal ferritin, negative autoimmune serologies, and abdominal ultrasound showing hepatic echogenicity without fibrosis, who consumes 4–6 alcoholic drinks per week, what is the most likely diagnosis?
What are the causes of elevated ferritin in a patient with normal liver enzymes and no iron overload?
What are the potential causes of elevated lactate dehydrogenase (LDH) levels in a patient with Systemic Lupus Erythematosus (SLE) and an inappropriate bone marrow response?
In a 26-year-old patient with elevated ferritin and severe diffuse fatty infiltration of the liver on ultrasound, what is the appropriate management?
Is it safe to administer intravenous L-ornithine‑L‑aspartate (LOLA) 30 g in 60 mL over 24 hours?
When should intravenous magnesium sulfate be considered for a patient with acute severe asthma exacerbation that is not improving after high‑dose inhaled β2‑agonists, systemic corticosteroids, and supplemental oxygen?
In a middle‑aged woman with a prior ischemic stroke and residual neurologic deficits who now presents with acute dyspnea, hypoxemia, hemoptysis, leukocytosis, an elevated D‑dimer, and CT showing peripheral ground‑glass opacities and consolidations compatible with pulmonary infarction, along with cardiomegaly and elevated pulmonary pressures (Wells score 4.5, intermediate‑high probability for pulmonary embolism) who is hemodynamically stable, what are the optimal management steps, expected prognosis, and is surgical intervention indicated?
After coronary stent placement, what is the recommended waiting period before performing an elective colonoscopy for drug‑eluting versus bare‑metal stents?
What is the appropriate dosing, schedule, and monitoring for estradiol vaginal cream in a postmenopausal woman with symptomatic vaginal atrophy, dryness, or dyspareunia?
What is the likely cause of a rising bilirubin to 1.8 mg/dL with normal liver enzymes in a patient who consumes >50% fast food, and what evaluation and management are recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.